NASDAQ
CMND

Clearmind Medicine Inc. Common Shares

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Clearmind Medicine Inc. Common Shares Stock Price

Vitals

Today's Low:
$0.3946
Today's High:
$0.4106
Open Price:
$0.399
52W Low:
$0.366
52W High:
$15
Prev. Close:
$0.406
Volume:
61360

Company Statistics

Market Cap.:
$3.18 million
Book Value:
2.075
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
-117.69%
Return on Equity TTM:
-238.22%

Company Profile

Clearmind Medicine Inc. Common Shares had its IPO on 2021-08-16 under the ticker symbol CMND.

The company operates in the Healthcare sector and Biotechnology industry. Clearmind Medicine Inc. Common Shares has a staff strength of 0 employees.

Stock update

Shares of Clearmind Medicine Inc. Common Shares opened at $0.4 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.39 - $0.41, and closed at $0.41.

This is a +0.99% increase from the previous day's closing price.

A total volume of 61,360 shares were traded at the close of the day’s session.

In the last one week, shares of Clearmind Medicine Inc. Common Shares have increased by +1.49%.

Clearmind Medicine Inc. Common Shares's Key Ratios

Clearmind Medicine Inc. Common Shares has a market cap of $3.18 million, indicating a price to book ratio of 27.7729 and a price to sales ratio of 0.

In the last 12-months Clearmind Medicine Inc. Common Shares’s revenue was $0 with a gross profit of $0 and an EBITDA of $-8895167. The EBITDA ratio measures Clearmind Medicine Inc. Common Shares's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Clearmind Medicine Inc. Common Shares’s operating margin was 0% while its return on assets stood at -117.69% with a return of equity of -238.22%.

In Q4, Clearmind Medicine Inc. Common Shares’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Clearmind Medicine Inc. Common Shares’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-4.48 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Clearmind Medicine Inc. Common Shares’s profitability.

Clearmind Medicine Inc. Common Shares stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -0.7446. Its price to sales ratio in the trailing 12-months stood at 0.

Clearmind Medicine Inc. Common Shares stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$6.21 million
Total Liabilities
$1.07 million
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Clearmind Medicine Inc. Common Shares ended 2024 with $6.21 million in total assets and $0 in total liabilities. Its intangible assets were valued at $6.21 million while shareholder equity stood at $5.14 million.

Clearmind Medicine Inc. Common Shares ended 2024 with $0 in deferred long-term liabilities, $1.07 million in other current liabilities, 17691059.00 in common stock, $-16309417.00 in retained earnings and $0 in goodwill. Its cash balance stood at $4.50 million and cash and short-term investments were $4.68 million. The company’s total short-term debt was $27,017 while long-term debt stood at $0.

Clearmind Medicine Inc. Common Shares’s total current assets stands at $5.98 million while long-term investments were $0 and short-term investments were $180225.00. Its net receivables were $369143.00 compared to accounts payable of $900872.00 and inventory worth $0.

In 2024, Clearmind Medicine Inc. Common Shares's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Clearmind Medicine Inc. Common Shares paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.41
52-Week High
$15
52-Week Low
$0.366
Analyst Target Price
$

Clearmind Medicine Inc. Common Shares stock is currently trading at $0.41 per share. It touched a 52-week high of $15 and a 52-week low of $15. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.43 and 200-day moving average was $1.83 The short ratio stood at 0.08 indicating a short percent outstanding of 0%.

Around 943.6% of the company’s stock are held by insiders while 308.3% are held by institutions.

Frequently Asked Questions About Clearmind Medicine Inc. Common Shares

The stock symbol (also called stock or share ticker) of Clearmind Medicine Inc. Common Shares is CMND

The IPO of Clearmind Medicine Inc. Common Shares took place on 2021-08-16

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
$17.99
0.05
+0.28%
$0.3
-0.02
-6.06%
$879.35
-30.6
-3.36%
$9.27
-0.05
-0.54%
$1.03
-0.01
-0.96%
$98.22
1.19
+1.23%
$0.62
0
+0.29%
$2.89
-0.04
-1.37%
$10.71
-0.02
-0.19%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Address

1220 West 6th Avenue, Vancouver, BC, Canada, V6H 1A5